Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $33.0 million.

  • Bio-Techne's Current Deferred Revenue rose 855.26% to $33.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $33.0 million, marking a year-over-year increase of 855.26%. This contributed to the annual value of $35.3 million for FY2025, which is 1688.74% up from last year.
  • Latest data reveals that Bio-Techne reported Current Deferred Revenue of $33.0 million as of Q4 2025, which was up 855.26% from $32.7 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Current Deferred Revenue registered a high of $35.6 million during Q1 2025, and its lowest value of $19.7 million during Q1 2021.
  • In the last 5 years, Bio-Techne's Current Deferred Revenue had a median value of $26.2 million in 2023 and averaged $27.2 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 5000.0% in 2021, then plummeted by 352.94% in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Current Deferred Revenue stood at $20.8 million in 2021, then grew by 12.98% to $23.5 million in 2022, then rose by 28.09% to $30.1 million in 2023, then rose by 1.0% to $30.4 million in 2024, then increased by 8.55% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q4 2025, $32.7 million for Q3 2025, and $35.3 million during Q2 2025.